Abstract
Estrogens (Es) play a crucial role in breast cancer (BC) development. Aromatase (CYP19), a cytochrome P450, is the enzyme that synthesizes Es. Using enzyme activity measurements (1–3), immunocytochemistry (4–7), and RT-PCR analysis (8, 9), aromatase is expressed at a higher level in human BC tissue than in normal breast tissue. Cell culture (10,11), animal experiments using aromatase-transfected BC cells (12, 13), and transgenic mouse studies (14) have demonstrated that in-situ produced E plays a more important role than circulating Es in breast tumor promotion. In addition, tumor aromatase has been shown to stimulate BC growth in both an autocrine and aparacrine manner (15). RT-PCR and gene transcriptional studies have revealed that in normal tissue, the aromatase promoter switches from a glucocorticoid-stimulated promoter, 1.4, to the cAMP-stimulated promoters, 1.3 and II, in cancerous tissue (9, 16, 17). Suppression of in-situ E biosynthesis can be achieved by the prevention of aromatase expression, or by the inhibition of aromatase activity in breast tumors. Our laboratory has devoted significant effort to understand the regulatory mechanism of aromatase expression in BC tissue and to determine the structure- function relationship of aromatase. The information obtained from our studies will help in developing approaches to repress aromatase/E biosynthesis in BC tissue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
James VHT, McNeill JM, Lai LC etal. (1987) Aromatase activity in normal breast and breast tumor tissues:in vivoandin vitrostudies. Steroids 50: 269–279.
Miller WR, O’Neill J (1987) The importance of local synthesis of estrogen within the breast. Steroids 50: 537–548.
Miller WR, Mullen P, Sourdaine P etal. (1997) Regulation of aromatase activity within the breast. J Steroid Biochem Molec Biol 61:193–202.
Esteban JM, Warsi Z, Haniu M etal. (1992) Detection of intratumoral aromatase in breast carcinomas, an immunohistochemical study with clinico-pathologic correlation. J Amer Pathol 140:337–343.
Sasano H, Nagura H, Harada N etal. (1994) Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25:530–535.
Santen RJ, Martel J, Hoagland M etal. (1994) Stromal spindle cells contain aromatase in human breast tumors. J. Clin Endocrinol Metab 79:627–632.
Lu Q, Nakamura J, Savinov A etal. (1996) Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137:3061–3077.
Bulum SE, Price TM, Mahendroo MS etal. (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77:1622–1628.
Harada N (1997) Aberrant expression of aromatase in breast cancer tissues. J Steroid Biochem Molec Biol 61:175–184.
Santner SJ, Chen S, Zhou D etal. (1993) Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J Steroid Biochem Molec Biol 44:611–616.
Macaulay VM, Nicholls JE, Gledhill J etal. (1994) Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br J Cancer 69:77–83.
Yue W, Zhou D, Chen S etal. (1994) A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res 54:5092–5095.
Dowsett M, Lee K, Macaulay M etal. (1996) The control and biological importance of intratumoural aromatase in breast cancer. J Steroid Biochem Molec Biol 56:145–150.
Tekmal RR, Ramachandra N, Gubba S etal. (1996) Overexpression of int- 5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res 56: 3180–3185.
Sun XZ, Zhou D, Chen S (1997) Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture studyinvolving aromatase transfected MCF-7 andT-47D cells. J Steroid Biochem Molec Biol 63:29–36.
Zhou C, Zhou D, Esteban J etal. (1996) Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction (RT-PCR). J Steroid Biochem Molec Biol 59:163–171.
Bulun SE, Noble LS, Takayama K etal. (1997) Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Molec Biol 61: 133–139.
Shozu M, Zhao Y, Bulun SE etal. (1998) Multiple splicing events involved in regulation of human aromatase expression by a novel promoter 1.6. Endocrinology 139: 1610–1617.
Mahendroo MS, Mendelson CR, Simpson ER (1993) Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 268:19463–19470.
Means GD, Kilgore MW, Mahendroo MS etal. (1991) Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Molecular Endocrinol 5:2005–2013.
Wang J, Chen S (1992) Identification of a promoter and a silencer at the 3Õ- end of the first intron of the human aromatase gene. Molecular Endocrinol 6:1479–1488.
Zhou D, Clarke P, Wang J etal. (1996) Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells. J Biol Chem 271:15194–15202.
Zhou D, Chen S (1998) Characterizaiton of a sliencer element in the human aromatase gene. Arch Biochem Biophys 353:213–220.
Michael MD, Kilgore MW, Morohashi KI etal. (1994) Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem 270:13561–13466.
Zhou D, Chen S (1998) Identification and characterization of a c AMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene. Molecular Endocrinol submitted.
Zhao Y, Agarwal VR, Mendelson CR etal. (1997) Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. J Steroid Biochem Molec Biol 61:203–210.
Aronica SM, Kraus WL, Katzenellenbogen BS (1994) Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP- regulated gene transcription. Proc Natl Acad Sci USA 91:8517–8521.
Zhou D, Pompon D, Chen S (1991) Structure-function studies of human aromatase by site-directed mutagenesis: Kinetic properties of mutants Pro308 - Phe, Tyr361 - Phe, Tyr361 - Leu, and Phe406 - Arg. Proc Natl Acad Sci USA 88:410–414.
Zhou D, Korzekwa KR, Poulos T etal. (1992) A site-directed mutagenesis study of human placental aromatase. J Biol Chem 267: 762–768.
Chen S, Zhou D (1992) Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments. J Biol Chem 267: 22587–22594.
Zhou D, Cam LL, Laughton CA etal. (1994) A mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450. J Biol Chem 269:19501–19508.
Kao YC, Cam LL, Laughton CA etal. (1996) Binding characteristics of seven inhibitors of human aromatase. A site-directed mutagenesis study. Cancer Res 56:451–460.
Kao YC, Zhou C, Sherman M etal. (1998) Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environmental Health Perspectives 106:85–92.
Chen S, Sun XZ, Kao YC etal. (1998) Suppression of breast cancer cell growth with grape juice. Pharmaceutical Biol, in press.
Coombes RC, Goss PE, Dowsett M etal. (1987) 4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer. Steroids 50:245–252.
Steele V, Lubet R, Eto I etal. (1997) Effect of animal age on the chemopreventive effects of selected agents using a MNU-induced rat mammary cancer model. Proceedings of the 88th Annual Meeting of American Association for Cancer Research, 12-16 April 1997, San Diego, CA; Abst. 2438.
Lubet R , Bowden C, De Coster R etal. (1997) Vorozole: Effects on MNU- induced rat mammary tumors. Proceedings of the 88th Annual Meeting of American Association for Cancer Research, 12–16 April 1997, San Diego, CA; Abst. 2491.
Kumar R, Sukumar S, Barbacid M (1990) Activation of ras oncogenes preceding the onset of neoplasia. Science 248:1101–1104.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag New York, Inc.
About this paper
Cite this paper
Chen, S., Zhou, D., Kao, YC., Yang, C., Grube, B. (2001). Control of Estrogen Biosynthesis in Breast Cancer. In: Li, J.J., Li, S.A., Daling, J.R. (eds) Hormonal Carcinogenesis III. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2092-3_26
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2092-3_26
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7411-7
Online ISBN: 978-1-4612-2092-3
eBook Packages: Springer Book Archive